Evidence map›Paper›PMID 24337294›Full record

ArticleScience (New York, N.Y.)2013

Erythropoietin derived by chemical synthesis.

Ping Wang, Suwei Dong, Jae-Hung Shieh, Elizabeth Peguero, Ronald Hendrickson, Malcolm A S Moore, Samuel J Danishefsky

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed.

  1. Article
  2. Article
  3. Revealing the Biological Effect of theJournal of the American Chemical Society · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Backbone Protecting Groups for Enhanced Peptide and Protein Synthesis.Angewandte Chemie (International ed. in English) · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Total synthesis of interleukin-2Chemical science · 2023
    Article
  19. Article
  20. Synthesis of glycopeptides and glycopeptide conjugates.Organic & biomolecular chemistry · 2022
    Review

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Ping Wang *Laboratory for Bioorganic Chemistry, Sloan-Kettering Institute for Cancer Research, 1275 York Avenue, New York, NY 10065, USA.
Suwei Dong *Laboratory for Bioorganic Chemistry, Sloan-Kettering Institute for Cancer Research, 1275 York Avenue, New York, NY 10065, USA.
Jae-Hung ShiehCell Biology Program, Sloan-Kettering Institute for Cancer Research, 1275 York Avenue, New York, NY 10065, USA.
Elizabeth PegueroCell Biology Program, Sloan-Kettering Institute for Cancer Research, 1275 York Avenue, New York, NY 10065, USA.
Ronald HendricksonDepartment of Pharmacology and Chemistry, Sloan-Kettering Institute for Cancer Research, 1275 York Avenue, New York, NY 10065, USA.
Malcolm A S MooreCell Biology Program, Sloan-Kettering Institute for Cancer Research, 1275 York Avenue, New York, NY 10065, USA.
Samuel J DanishefskyLaboratory for Bioorganic Chemistry, Sloan-Kettering Institute for Cancer Research, 1275 York Avenue, New York, NY 10065, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NEW SYNTHETIC REACTIONS FOR ACTIVE PRINCIPLESR01HL025848 · NHLBI · YALE UNIVERSITY · PI DANISHEFSKY, SAMUEL J · 1985 to 2012
$5.6M
New Synthetic Reactions to Reach Bioactive ProteinsR01GM109760 · NIGMS · SLOAN-KETTERING INST CAN RESEARCH · PI LUO, MINKUI · 2014 to 2017
$1.7M
NCI NIH HHS P30 CA008748NHLBI NIH HHS HL025848NHLBI NIH HHS R01 HL025848NIGMS NIH HHS R01 GM109760
6 · The paper itself

Abstract

Erythropoietin is a signaling glycoprotein that controls the fundamental process of erythropoiesis, orchestrating the production and maintenance of red blood cells. As administrated clinically, erythropoietin has a polypeptide backbone with complex dishomogeneity in its carbohydrate domains. Here we describe the total synthesis of homogeneous erythropoietin with consensus carbohydrate domains incorporated at all of the native glycosylation sites. The oligosaccharide sectors were built by total synthesis and attached stereospecifically to peptidyl fragments of the wild-type primary sequence, themselves obtained by solid-phase peptide synthesis. The glycopeptidyl constructs were joined by chemical ligation, followed by metal-free dethiylation, and subsequently folded. This homogeneous erythropoietin glycosylated at the three wild-type aspartates with N-linked high-mannose sialic acid-containing oligosaccharides and O-linked glycophorin exhibits Procrit-level in vivo activity in mice.

Indexed as

Amino Acid SequenceAnimalsAspartic AcidCells, CulturedConsensus SequenceDose-Response Relationship, DrugErythrocyte CountErythropoietinGlycophorinsGlycosylationInjections, SubcutaneousMannoseMiceMice, Inbred C57BLMolecular Sequence DataN-Acetylneuraminic AcidAspartic AcidErythropoietinGlycophorinsMannoseN-Acetylneuraminic AcidOligosaccharides

Identifiers

PMID24337294
PMCPMC4080428

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.